Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The Toll-like receptor (TLR) family consists of phylogenetically conserved transmembrane proteins, which function as mediators of innate immunity for recognition of pathogen-derived ligands and subsequent cell activation via the Toll/IL-1R signal pathway. Here, we show that human TLR9 (hTLR9) expression in human immune cells correlates with responsiveness to bacterial deoxycytidylate-phosphate-deoxyguanylate (CpG)-DNA. Notably “gain of function” to immunostimulatory CpG-DNA is achieved by expressing TLR9 in human nonresponder cells. Transfection of either human or murine TLR9 conferred responsiveness in a CD14- and MD2-independent manner, yet required species-specific CpG-DNA motifs for initiation of the Toll/IL-1R signal pathway via MyD88. The optimal CpG motif for hTLR9 was GTCGTT, whereas the optimal murine sequence was GACGTT. Overall, these data suggest that hTLR9 conveys CpG-DNA responsiveness to human cells by directly engaging immunostimulating CpG-DNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNA
Chu, W.-M., Gong, X., Li, Z.-W., Takabayashi, K., Ouyang, H.-H., Chen, Y., Lois, A., Chen, D. J., Li, G. C., Karin, M., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00194-x · Cited by 178
RetractedDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Self-citationHigh-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
Self-citationToll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Self-citation
Cited by
Items 101–146 of 146
Type I interferons: crucial participants in disease amplification in autoimmunity
Hall, J. C., & Rosen, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.237 · Cited by 265
Innate Sensing of Viruses by Toll-Like Receptors
Boehme, K. W., & Compton, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.7867-7873.2004 · Cited by 265
Yang, W., Zerbe, H., Petzl, W., Brunner, R. M., Günther, J., Draing, C., von Aulock, S., Schuberth, H.-J., & Seyfert, H.-M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.004 · Cited by 262
Toll-Like Receptors in Normal and Cystic Fibrosis Airway Epithelial Cells
Muir, A., Soong, G., Sokol, S., Reddy, B., Gomez, M. I., van Heeckeren, A., & Prince, A. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0329oc · Cited by 259
Adiponectin inhibits Toll‐like receptor family‐induced signaling
Yamaguchi, N., Argueta, J. G. M., Masuhiro, Y., Kagishita, M., Nonaka, K., Saito, T., Hanazawa, S., & Yamashita, Y. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.11.019 · Cited by 259
Challenges in developing personalized neoantigen cancer vaccines
Katsikis, P. D., Ishii, K. J., & Schliehe, C. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00937-y · Cited by 258
Taking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258
Mempel, M., Voelcker, V., Köllisch, G., Plank, C., Rad, R., Gerhard, M., Schnopp, C., Fraunberger, P., Walli, A. K., Ring, J., et al. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12630.x · Cited by 256
Yasuda, K., Yu, P., Kirschning, C. J., Schlatter, B., Schmitz, F., Heit, A., Bauer, S., Hochrein, H., & Wagner, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6129 · Cited by 255
Self-citationFenske, D. B., & Cullis, P. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.25 · Cited by 253
Family Iridoviridae: Poor Viral Relations No Longer
Chinchar, V. G., Hyatt, A., Miyazaki, T., & Williams, T. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-68618-7_4 · Cited by 252
Martino, A. T., Suzuki, M., Markusic, D. M., Zolotukhin, I., Ryals, R. C., Moghimi, B., Ertl, H. C. J., Muruve, D. A., Lee, B., & Herzog, R. W. (2011) · Blood · doi:10.1182/blood-2010-10-314518 · Cited by 246
Hyakkoku, K., Hamanaka, J., Tsuruma, K., Shimazawa, M., Tanaka, H., Uematsu, S., Akira, S., Inagaki, N., Nagai, H., & Hara, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.054 · Cited by 244
Self-citationKumar, M. V., Nagineni, C. N., Chin, M. S., Hooks, J. J., & Detrick, B. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.018 · Cited by 243
“Because TLR 3 gene expression was identified in RPE cells and because the RPE cells are a site of replication for both RNA and DNA viruses, we further investigated TLR 3 signaling in these cells.”
InfluentialBurclaff, J., Bliton, R. J., Breau, K. A., Ok, M. T., Gomez-Martinez, I., Ranek, J. S., Bhatt, A. P., Purvis, J. E., Woosley, J. T., & Magness, S. T. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.007 · Cited by 242
TLRs Govern Neutrophil Activity in Aspergillosis
Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L., & Romani, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7406 · Cited by 242
“R848 (a stimulus for TLR7 and TLR8) and CpG oligonucleotides 2006 (CpG-ODN, as a TLR9 stimulus) of proven immunostimulatory sequences were obtained as described (21, 22).”
MethodSelf-citationRepetitive Elements in Mammalian Telomeres Suppress Bacterial DNA-Induced Immune Activation
Gursel, I., Gursel, M., Yamada, H., Ishii, K. J., Takeshita, F., & Klinman, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1393 · Cited by 241
Interferon-producing cells: on the front line in immune responses against pathogens
Colonna, M., Krug, A., & Cella, M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00349-7 · Cited by 238
MDA-5 Recognition of a Murine Norovirus
McCartney, S. A., Thackray, L. B., Gitlin, L., Gilfillan, S., Virgin IV, H. W., & Colonna, M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000108 · Cited by 228
“Among the TLRs, TLR 7 and 8 recognize ssRNA [29,30,31], TLR9 recognizes DNA [32,33], while TLR3 signals in”
BackgroundKoedel, U., Angele, B., Rupprecht, T., Wagner, H., Roggenkamp, A., Pfister, H.-W., & Kirschning, C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.438 · Cited by 223
“2006 (2 M; in a phosphothioate protected form; TIB MOLBIOL, Berlin, Germany) for 16 h (26).”
BackgroundSelf-citationIto, T., Wang, Y.-H., & Liu, Y.-J. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0180-4 · Cited by 216
“bacterial and viral DNA [25, 26].”
TLR2: Cellular Sensor for Microbial and Endogenous Molecular Patterns
Kirschning, C. J., & Schumann, R. R. (2002) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59430-4_8 · Cited by 211
Self-citationPashenkov, M., Goëss, G., Wagner, C., Hörmann, M., Jandl, T., Moser, A., Britten, C. M., Smolle, J., Koller, S., Mauch, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9129 · Cited by 210
Activation of Toll-Like Receptor 9 by DNA from Different Bacterial Species
Dalpke, A., Frank, J., Peter, M., & Heeg, K. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.940-946.2006 · Cited by 209
“It was noted early that stimulation by bacterial DNA could be mimicked by the use of [CG]-containing synthetic oligodesoxynucleotides (CpG-ODNs) (11).”
MethodInfluentialCpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
Verthelyi, D., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1659 · Cited by 199
“It was recently established that Toll-like receptor 9 plays a critical role in CpG ODN-mediated activation of human and murine immune cells (35, 36).”
BackgroundNeuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9)
Iliev, A. I., Stringaris, A. K., Nau, R., & Neumann, H. (2004) · The FASEB Journal · doi:10.1096/fj.03-0670fje · Cited by 192
“Recently, unmethylated bacterial DNA has been shown to possess the capacity of inducing sustained inflammation via stimulation of TLR9 (4, 5).”
BackgroundToll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System
Ozato, K., Tsujimura, H., & Tamura, T. (2002) · BioTechniques · doi:10.2144/oct0208 · Cited by 189
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9
Takeshita, F., Gursel, I., Ishii, K. J., Suzuki, K., Gursel, M., & Klinman, D. M. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.009 · Cited by 189
“These findings confirm the importance of TLR9 as a receptor for CpG DNA, and suggest that this receptor accounts for species-specific differences in the response to bacterial DNA [15].”
BackgroundAutomatic quantification of in vitro NET formation
Brinkmann, V., Goosmann, C., Kühn, L. I., & Zychlinsky, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00413 · Cited by 187
“…to induce NET formation, namely the synthetic lipopeptide (BLP, Pam3Cys-SKKK), a ligand of the TLR1/2-dimer (Aliprantis et al., 1999; Brightbill et al., 1999), a synthetic oligonucleotide rich in CpG-motifs that activates TLR9 (Bauer et al., 2001) and flagellin, a TLR5 ligand (Hayashi et al., 2001).”
BackgroundAltered Monocyte Responses to Defined TLR Ligands in Patients With Primary Biliary Cirrhosis *
Mao, T. K., Lian, Z.-X., Selmi, C., Ichiki, Y., Ashwood, P., Ansari, A. A., Coppel, R. L., Shimoda, S., Ishibashi, H., & Gershwin, E. M. (2005) · Hepatology · doi:10.1002/hep.20859 · Cited by 185
Wagner, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00144-3 · Cited by 181
Self-citationThe Expression and Functions of Toll-Like Receptors in Atherosclerosis
Cole, J. E., Georgiou, E., & Monaco, C. (2010) · Mediators of Inflammation · doi:10.1155/2010/393946 · Cited by 177
“Human B cells express TLR1, TLR6, TLR7, TLR9, and TLR10 [27, 68, 77, 78] and secrete cytokines such as IL6 and TNFα in response to stimulation with CpG oligonucleotides [27, 78, 79] although discrepancies in the literature exist.”
BackgroundInfluentialTargeting the TLR9–MyD88 pathway in the regulation of adaptive immune responses
Huang, X., & Yang, Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.501333 · Cited by 121
Tsujimura, H., Tamura, T., Kong, H. J., Nishiyama, A., Ishii, K. J., Klinman, D. M., & Ozato, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6820 · Cited by 121
Nucleic acid‐sensing TLR s and autoimmunity: novel insights from structural and cell biology
Pelka, K., Shibata, T., Miyake, K., & Latz, E. (2016) · Immunological Reviews · doi:10.1111/imr.12375 · Cited by 110
“TLR3 recognizes dsRNA (12), TLR7 (13, 14), human TLR8 (14) and mouse TLR13 detect ssRNA (15, 16), and TLR9 responds to CpG-rich ssDNA (17, 18).”
BackgroundCytoplasmic Mechanisms of Recognition and Defense of Microbial Nucleic Acids
Hu, M.-M., & Shu, H.-B. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062903 · Cited by 110
Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity
Zahid, A., Ismail, H., Li, B., & Jin, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613039 · Cited by 100
“The CpG motifs in mammals are methylated at the cytosine base (80), while the bacterial and viral CpG sites are un-methylated; therefore, TLR9 can distinguish between self and non-self to prevent unwanted immune reactivity (81).”
BackgroundThe biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus
van der Kuyl, A. C., & Berkhout, B. (2012) · Retrovirology · doi:10.1186/1742-4690-9-92 · Cited by 94
Zhao, H., Hemmi, H., Akira, S., Cheng, S. H., Scheule, R. K., & Yew, N. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.012 · Cited by 85
Self-citationBode, C., Fox, M., Tewary, P., Steinhagen, A., Ellerkmann, R. K., Klinman, D., Baumgarten, G., Hornung, V., & Steinhagen, F. (2016) · European Journal of Immunology · doi:10.1002/eji.201546113 · Cited by 79
Schnödt, M., & Büning, H. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.188 · Cited by 77
Concanavalin A induced expression of Toll-like receptors in murine peritoneal macrophages in vitro
Sodhi, A., Tarang, S., & Kesherwani, V. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.11.014 · Cited by 67
Frederiksen, H. R., Haukedal, H., & Freude, K. (2019) · BioMed Research International · doi:10.1155/2019/7420189 · Cited by 63
Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Zulliger, R., Conley, S. M., & Naash, M. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.007 · Cited by 50
DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations
Schnödt, M., Schmeer, M., Kracher, B., Krüsemann, C., Espinosa, L. E., Grünert, A., Fuchsluger, T., Rischmüller, A., Schleef, M., & Büning, H. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.60 · Cited by 39
Chanda, D., Hensel, J., Higgs, J., Grover, R., Kaza, N., & Ponnazhagan, S. (2017) · Genes · doi:10.3390/genes8090232 · Cited by 19
Metadata
- Authors
- Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-07-24
- Volume
- 98
- Issue
- 16
- Pages
- 9237-9242
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2069981713
- Cited by
- 1,533
- References
- 44
- FWCI
- 31.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.